Literature DB >> 8497049

Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.

M Jiang1, J Mak, A Ladha, E Cohen, M Klein, B Rovinski, L Kleiman.   

Abstract

We have identified the tRNAs which are incorporated into both wild-type human immunodeficiency virus type 1 strain IIIB (HIV-1IIIB) produced in COS-7 cells transfected with HIV-1 proviral DNA and mutant, noninfectious HIV-1Lai particles produced in a genetically engineered Vero cell line. The mutant proviral DNA contains nucleotides 678 to 8944; i.e., both long terminal repeats and the primer binding site are absent. As analyzed by two-dimensional polyacrylamide gel electrophoresis, both mutant and wild-type HIV-1 contain four major-abundance tRNA species, which include tRNA(1,2Lys), tRNA(3Lys) (the putative primer for HIV-1 reverse transcriptase) and tRNA(Ile). Identification was accomplished by comparing the electrophoretic mobilities and RNase T1 digests with those of tRNA(3Lys) and tRNA(1,2Lys) purified from human placenta and comparing the partial nucleotide sequence at the 3' end of each viral tRNA species with published tRNA sequences. Thus, the absence of the primer binding site in the mutant virus does not affect tRNA(Lys) incorporation into HIV-1. However, only the wild-type virus contains tRNA(3Lys) tightly associated with the viral RNA genome. The identification of the tightly associated tRNA as tRNA(3Lys) is based upon an electrophoretic mobility identical to that of tRNA(3Lys) and the ability of this RNA to hybridize with a tRNA(3Lys)-specific DNA probe. In addition to the four wild-type tRNA species, the mutant HIV-1-like particle contains two tRNA(His) species and three tRNA-sized species that we have been unable to identify. Their absence in wild-type virus makes it unlikely that they are required for viral infectivity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497049      PMCID: PMC237665          DOI: 10.1128/JVI.67.6.3246-3253.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis.

Authors:  F Harada; R C Sawyer; J E Dahlberg
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

2.  Virion-associated RNA primer for Rous sarcoma virus DNA synthesis: isolation from uninfected cells.

Authors:  R C Sawyer; F Harada; J E Dahlberg
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

3.  Amino-acid acceptor activity of the "70S-associated" 4S RNA from avian myeloblastosis virus.

Authors:  L J Rosenthal; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

4.  Small RNAs of Rous sarcoma virus: characterization by two-dimensional polyacrylamide gel electrophoresis and fingerprint analysis.

Authors:  R C Sawyer; J E Dahlberg
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Association of 4S ribonucleic acid with oncornavirus ribonucleic acids.

Authors:  E Erikson; R L Erikson
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

Review 6.  An analysis of the role of tRNA species as primers for the transcription into DNA of RNA tumor virus genomes.

Authors:  J M Taylor
Journal:  Biochim Biophys Acta       Date:  1977-03-21

7.  Ability of tryptophan tRNA to hybridize with 35S RNA of avian myeloblastosis virus and to prime reverse transcription in vitro.

Authors:  L C Waters; B C Mullin; T Ho; W K Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

8.  RNA-directed DNA synthesis by the DNA polymerase of Rous sarcoma virus: structural and functional identification of 4S primer RNA in uninfected cells.

Authors:  A J Faras; N A Dibble
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

9.  Studies on human tRNA. I. The rapid, large scale isolation and partial fractionation of placenta and liver tRNA.

Authors:  B A Roe
Journal:  Nucleic Acids Res       Date:  1975-01       Impact factor: 16.971

10.  Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis.

Authors:  G Peters; F Harada; J E Dahlberg; A Panet; W A Haseltine; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

View more
  109 in total

1.  The effect of mutations in the HIV-1 nucleocapsid protein on strand transfer in cell-free reverse transcription reactions.

Authors:  M Hsu; L Rong; H de Rocquigny; B P Roques; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1.

Authors:  S Cen; A Khorchid; J Gabor; L Rong; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.

Authors:  C Liang; X Li; L Rong; P Inouye; Y Quan; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.

Authors:  X Wei; M Götte; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 7.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

8.  Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.

Authors:  Tatiana V Ilina; Ryan L Slack; John H Elder; Stefan G Sarafianos; Michael A Parniak; Rieko Ishima
Journal:  J Mol Biol       Date:  2018-05-08       Impact factor: 5.469

9.  Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1.

Authors:  Y Huang; J Mak; Q Cao; Z Li; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.

Authors:  J M Whitcomb; B A Ortiz-Conde; S H Hughes
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.